Craig Wylie is a Senior Consultant with Cutter Consortium and a partner at Arthur D. Little. His expertise is in the epcific regulated functions of the life sciences industry, and in particular post-merger integration, R&D strategy and operations, inspection readiness and findings remediation. His background is in R&D and Quality Operations and he strongly believes that effective management of functions such as quality, regulatory, medical and safety should be an enabler of value within the organization, not a burden, and that executed effectively these functions guide thinking without stifling innovation.
Craig currently focuses on the effective implementation of quality and regulatory compliance within the highly regulated pharmaceutical company environment. He has worked with many of the world’s largest pharmaceutical firms has included work on remediation of warning letters and consent decrees.
Previously, Craig was a Partner at PA Consulting in the UK and the US, where he led the US team. He holds a BSc in computing science and management science from Stirling University. Craig can be reached at firstname.lastname@example.org.